Ensysce Biosciences Balance Sheet
Ensysce Biosciences's total assets for Q4 2025 were $7.45M, an increase of 134.39% from the previous quarter. ENSC total liabilities were $4.57M for the fiscal quarter, a 98.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.